RE:RE:RE:RE:AGM filled w details plus potential minor sht-term catalystsRGfcatspls, I commend you. You seem to be one of the few insightful people here. Between people posting unrelated information to those misleading readers,for example with suggestions that no pharma will partner until after an FDA approval (are they a new investor to biotech or a misleader), this is not a very informative or factual source of information.One question I had was whether the company will disclose the results of the 3rd party market analysis for the MCNA treatment to shareholders?This study was glossed over in the press release yesterday but is very important for shareholders especially new sharholders to quantify the revenue protential. This company is very unknown and if they truly want to be seen and heard that is a very important source of information for serious investors. Do you know if they are intending to make the info public?